2019
Sep 27 2019 AMIDEBIO awarded $1.56M NIH Phase II SBIR
2017
Nov 14 2017 Dr. Charles A. Stanley joins AmideBio’s Scientific Advisory Board
Nov 12 2017 Dr. David L. Snitman joins AmideBio’s Business Advisory Board
Nov 7 2017 AmideBio Closes $764,000 Preferred Equity Financing
Sep 24 2017 AmideBio awarded $338,387 NIH SBIR grant for congenital hyperinsulinism treatment
Jul 1 2017 AmideBio granted European patent protection for peptide production platform technology
2012
2011
Jun 16 2011 AmideBio Moves to New Location
2010
Jan 26 2010 AmideBio Closes Seed Financing